Fatiha Chigr

Prof. Fatiha Chigr


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2020 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
FCFatiha Chigr
Fatiha Chigr
MMMohamed Merzouki
Mohamed Merzouki
MNMohamed Najimi
Mohamed Najimi

12 October 2023 in Medicina
Verified
Journal Article
Open access
PDF file
AFAyoub Farihi
Ayoub Farihi
MBMohamed Bouhrim
Mohamed Bouhrim
FCFatiha Chigr
Fatiha Chigr
Amine ElbouzidiAmine Elbouzidi
Amine Elbouzidi
NOUREDDINE BENCHEIKHNOUREDDINE BENCHEIKH
NOUREDDINE BENCHEIKH
AAAhmed Omar Touhami Ahami
Ahmed Omar Touhami Ahami
Background and Objectives: Alzheimer’s disease (AD) stands as a pervasive neurodegenerative ailment of global concern, necessitating a relentless pursuit of remedies. This study aims to furnish a comprehensive exposition, delving into the intricate mechanistic actions of medicinal herbs and phytochemicals. Furthermore, we assess the potential of these compounds in inhibiting human acetylcholinesterase through molecular docking, presenting encouraging avenues for AD therapeutics. Materials and Methods: Our approach entailed a systematic exploration of phytochemicals like curcumin, gedunin, quercetin, resveratrol, nobiletin, fisetin, and berberine, targeting their capability as human acetylcholinesterase (AChE) inhibitors, leveraging the PubChem database. Diverse bioinformatics techniques were harnessed to scrutinize molecular docking, ADMET (absorption, distribution, metabolism, excretion, and toxicity), and adherence to Lipinski’s rule of five. Results: Results notably underscored the substantial binding affinities of all ligands with specific amino acid residues within AChE. Remarkably, gedunin exhibited a superior binding affinity (−8.7 kcal/mol) compared to the reference standard. Conclusions: These outcomes accentuate the potential of these seven compounds as viable candidates for oral medication in AD treatment. Notably, both resveratrol and berberine demonstrated the capacity to traverse the blood-brain barrier (BBB), signaling their aptitude for central nervous system targeting. Consequently, these seven molecules are considered orally druggable, potentially surpassing the efficacy of the conventional drug, donepezil, in managing neurodegenerative disorders.

22 May 2020 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
FCFatiha Chigr
Fatiha Chigr
MMMohamed Merzouki
Mohamed Merzouki
MNMohamed Najimi
Mohamed Najimi
We have read with great care and interest the article by Li et al The authors provide interesting elements with respect to the possible entry of severe acute respiratory syndrome coronavirus 2 at the brain area and plead for an implication of the central nervous system in respiratory problems linked to coronavirus disease. Here we provide additional elements that support those observations, notably the role of brainstem structures located in the medulla oblongata in modulating respiration. We also discussed the possible pathways the virus uses to cross the brain blood barrier and reach the brainstem.

12 January 2019 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
FOFatima Zahra Ouardi
Fatima Zahra Ouardi
HAHammou Anarghou
Hammou Anarghou
HMHafsa Malqui
Hafsa Malqui
NONabila Ouasmi
Nabila Ouasmi
MCMohammed Chigr
Mohammed Chigr
FCFatiha Chigr
Fatiha Chigr


24 September 2018 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
HMHafsa Malqui
Hafsa Malqui
HAHammou Anarghou
Hammou Anarghou
FOFatima Zahra Ouardi
Fatima Zahra Ouardi
NONabila Ouasmi
Nabila Ouasmi
MNMohamed Najimi
Mohamed Najimi
FCFatiha Chigr
Fatiha Chigr